Ubrogepant

Ubrogepant, sold under the brand name Ubrelvy, is a medication used for the acute (immediate) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults.[1][2] It is not indicated for the preventive treatment of migraine.[3] Ubrogepant is a small-molecule calcitonin gene-related peptide receptor antagonist.[4][5] It is the first drug in this class approved for the acute treat... [wikipedia]